Agility Health and Rehabilitation: Drug Restraint Violations - WA
When inspectors arrived at Agility Health and Rehabilitation in University Place this past June, they found a facility giving residents psychotropic medications in ways that limited those residents' ability to function. That is the specific language regulators use for a category of harm that sits inside a broader framework of abuse, neglect, and exploitation violations. It is not a paperwork problem. It is a finding that people living at this facility received medications that diminished what they could do, think, or feel, and that the facility had not demonstrated those medications were necessary.
The citation was one of 13 deficiencies inspectors recorded during the June 9 inspection. Agility Health and Rehabilitation has submitted no plan of correction.
Psychotropic medications, a category that includes antipsychotics, antidepressants, anti-anxiety drugs, and sedative-hypnotics, act directly on the brain. When used appropriately, they can reduce genuine suffering. When used to manage behavior that staff find difficult, or to keep residents quiet and compliant, they become a form of chemical restraint. The distinction matters enormously to the person receiving them. A resident sedated into passivity is a resident who cannot advocate for themselves, cannot participate in their own care, cannot maintain relationships with family, and cannot experience whatever quality of life remains available to them.
Federal regulators have tracked inappropriate psychotropic drug use in nursing homes for decades. The pattern is stubborn. Facilities that are understaffed find it easier to medicate a resident who wanders or shouts or resists care than to provide the one-on-one attention that might address the underlying need. A resident with dementia who calls out repeatedly may be frightened, in pain, or disoriented. A sedative stops the calling. It does not address the fear, the pain, or the confusion. It simply makes the resident easier to manage.
The violation at Agility was classified at Scope and Severity Level D, which means inspectors identified it as isolated in scope and found no actual harm documented at the time of the inspection. But the regulatory framework that produced this citation does not require that harm already be visible. It requires only that the potential for more than minimal harm exists. With psychotropic medications, that potential is not theoretical. These are drugs that affect balance, cognition, and the ability to swallow. Falls, aspiration pneumonia, and accelerated cognitive decline are among the documented risks. For elderly residents whose physical reserves are already limited, the margin between a medication's intended effect and a serious adverse event can be narrow.
What inspectors did not find, or at least did not document in the available narrative, is equally important. There is no indication that the facility had identified the problem on its own. There is no indication that a physician had recently reviewed the medications in question and determined they were no longer appropriate. The finding arrived because federal inspectors arrived. That sequence, external scrutiny producing a finding that internal oversight missed, is itself a finding about how this facility operates.
Agility Health and Rehabilitation has not filed a plan of correction. That is the formal mechanism through which a facility tells regulators what went wrong, why it went wrong, and what will be different going forward. Without one, there is no public record of the facility acknowledging the deficiency, no timeline for addressing it, and no stated commitment to the residents currently living there. The inspection record shows a problem identified and, so far, a facility that has not responded to it on paper.
The 13 total deficiencies cited during this inspection place Agility in a position that warrants attention from families considering the facility and from families whose relatives already live there. A single deficiency can reflect a momentary lapse. Thirteen deficiencies, across a single inspection cycle, suggest something more systemic about how the facility is being run. The psychotropic medication finding sits within the abuse and neglect category, which is where regulators place violations they consider most directly connected to resident dignity and safety.
University Place is a small city on the Puget Sound, southwest of Tacoma. Families choosing a nursing home in Pierce County have limited options, and that scarcity shapes the choices available to people who need skilled nursing care. A facility that receives 13 deficiency citations in a single inspection and files no plan of correction is a facility that families deserve to know about, in specific terms, before they make a decision they may not easily be able to reverse.
The residents at Agility who received psychotropic medications that limited their functioning did not, as far as the inspection record shows, have a meaningful say in that outcome. Residents in nursing homes have the right to be free from unnecessary medications, to have their care explained to them, and to refuse treatment. Whether those rights were honored in the cases that produced this citation is not something the available record resolves. What the record does establish is that inspectors found the medications unnecessary, that the potential for harm was real, and that the facility has offered no formal account of what it intends to do differently.
The family member who visits on a Sunday afternoon and notices that their mother seems more sedated than usual, or less able to track a conversation, or slower to recognize a familiar face, is observing something real. The clinical language in an inspection report, "unnecessary psychotropic medications that may restrain a resident's ability to function," translates into that Sunday afternoon observation. It translates into a person who was more present last month than they are today, and into the question of whether that change was inevitable or whether it was, in some measure, a choice the facility made on their behalf.
That question does not have a public answer yet. Agility Health and Rehabilitation has not provided one.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Agility Health and Rehabilitation from 2026-06-09 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: July 31, 2026 · Our methodology
AGILITY HEALTH AND REHABILITATION in UNIVERSITY PLACE, WA was cited for violations during a health inspection on June 9, 2026.
That is the specific language regulators use for a category of harm that sits inside a broader framework of abuse, neglect, and exploitation violations.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.